Effectiveness and cost of failure mode and effects analysis methodology to reduce neurosurgical site infections

Alexander R Hover1, William W Sistrunk2, Robert M Cavagnol2

  • 1Mercy Medical Research Institute, Springfield, MO Alexander.hover@mercy.net.

Insights

Failure Mode and Effects Analysis (FMEA) significantly reduced neurosurgery infections at Mercy Hospital Springfield, lowering rates by 41% and saving costs. This quality improvement initiative demonstrated clinical cost-effectiveness.

Area of Science:

  • Healthcare Quality Improvement
  • Patient Safety
  • Surgical Site Infections

Background:

  • Mercy Hospital Springfield, a tertiary care facility, maintained a stable inpatient elective neurosurgery infection rate of 2.15% from June 2009 to January 2011.
  • Healthcare-associated infections pose significant morbidity and economic burdens.

Purpose of the Study:

  • To implement and evaluate the effectiveness of the Failure Mode and Effects Analysis (FMEA) methodology in reducing inpatient neurosurgery infections.
  • To assess the clinical cost-effectiveness of FMEA implementation.

Main Methods:

  • The Failure Mode and Effects Analysis (FMEA) methodology was applied to identify and mitigate risks associated with inpatient neurosurgery infections.
  • Infection rates were monitored before and after FMEA implementation.

Main Results:

  • Following FMEA implementation, the overall elective neurosurgery infection rate decreased to 1.51% and was sustained through May 2012.
  • A 41% reduction in deep-space and organ infection rates was observed post-FMEA (P = .052).
  • Overall hospital clean surgery infection rates did not show a comparable decrease, suggesting a specific FMEA effect.

Conclusions:

  • FMEA implementation resulted in a significant reduction in neurosurgery infections, with an estimated 14 fewer infections, $270,270 in savings, a 168-day reduction in length of stay, and 22 fewer readmissions.
  • The study concludes that FMEA implementation is a clinically cost-effective strategy for reducing healthcare-associated infections in surgical settings.